SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057017
Filing Date
2024-05-09
Accepted
2024-05-09 16:20:33
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20240331.htm   iXBRL 10-Q 1331336
2 EX-31.1 ivvd-ex31_1.htm EX-31.1 17124
3 EX-31.2 ivvd-ex31_2.htm EX-31.2 17033
4 EX-32.1 ivvd-ex32_1.htm EX-32.1 10517
5 EX-32.2 ivvd-ex32_2.htm EX-32.2 9986
  Complete submission text file 0000950170-24-057017.txt   6217875

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20240331.xsd EX-101.SCH 1146278
68 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20240331_htm.xml XML 891496
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 24931034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)